Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine

The Journal of Infectious Diseases
R DaganP Yagupsky

Abstract

Children 12-18 months old were randomized to receive one dose of a conjugate heptavalent pneumococcal vaccine, two doses of the same vaccine, or one dose of a 23-valent native polysaccharide vaccine. Before immunization, pneumococci included in the conjugate vaccine were isolated from 24% of the children, and an antibiotic-resistant pneumococcus was isolated from 22% of the children. The vaccines had no effect on carriage of non-vaccine-type pneumococci. In contrast, there was a significant reduction in carriage of vaccine-type pneumococci 3 months after one dose and 1 month after a second dose of conjugate vaccine (from 25% to 9% and 7%, respectively; P < .001). No effect was seen after vaccination with the nonconjugate vaccine. One year after immunization, carriage of antibiotic-resistant vaccine-type pneumococci in children receiving conjugate vaccine was lower than that in children receiving the nonconjugate vaccine (4% vs. 14%, P = .042). Conjugate pneumococcal vaccines may reduce spread of pneumococci in the community.

Citations

Mar 25, 1998·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·R Dagan
May 20, 2005·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S M McChleryS C Clarke
Apr 15, 2008·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M Nowosiad, S Giedrys-Kalemba
Nov 30, 2000·Current Infectious Disease Reports·M G Ottolini
Apr 26, 2005·Current Infectious Disease Reports·Tsering Y Sherpa, Howard L Leaf
May 31, 2008·Current Infectious Disease Reports·Eugene Leibovitz
May 31, 2008·Current Infectious Disease Reports·Catherine A Lexau
Nov 30, 2000·Current Infectious Disease Reports·R L Wientzen, C Barbey-Morel
May 20, 2004·Vaccine·D BogaertR de Groot
Dec 12, 2001·Primary Care·A L Campbell, K A Bryant
Jun 7, 2002·International Journal of Pediatric Otorhinolaryngology·Ingeborg J DhoogeGer T Rijkers
Nov 30, 1999·International Journal of Pediatric Otorhinolaryngology·A LeibermanD M Fliss
Apr 23, 2003·Vaccine·Katherine L O'Brien, Ron Dagan
Aug 26, 1998·Vaccine·P F Wright, P F Wright
Sep 2, 1999·Vaccine·K Mulholland
Apr 13, 1999·Infectious Disease Clinics of North America·H Ahmad, E K Chapnick
Sep 2, 1999·Infectious Disease Clinics of North America·K P Klugman, S A Madhi
Sep 2, 1999·Infectious Disease Clinics of North America·H Peltola
Apr 17, 2001·Infectious Disease Clinics of North America·G A Poland
Aug 1, 1997·Trends in Microbiology·A BlanchardM L Gougeon
Aug 1, 1997·Trends in Microbiology·S Rowland-Jones, R Tan
Mar 6, 1999·Current Opinion in Microbiology·J B McCormick
Jul 18, 2002·Scandinavian Journal of Immunology·T Wuorimaa, H Käyhty
Aug 30, 2002·Seminars in Pediatric Infectious Diseases·Gary D Overturf
Jan 3, 2001·The New England Journal of Medicine·C G WhitneyUNKNOWN Active Bacterial Core Surveillance Program of the Emerging Infections Program Network
Feb 15, 2001·The New England Journal of Medicine·J EskolaUNKNOWN Finnish Otitis Media Study Group
May 2, 2003·The New England Journal of Medicine·Cynthia G WhitneyUNKNOWN Active Bacterial Core Surveillance of the Emerging Infections Program Network
Oct 3, 2003·The New England Journal of Medicine·Keith P KlugmanUNKNOWN Vaccine Trialists Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.